Possible anti-Parkinson properties of N-(α-linolenoyl) tyrosine: A new molecule

Pharmacology Biochemistry and Behavior

Volumn 72, Issue 1-2, 2002, Pages 7-11

  Yehuda, Shlomo ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

Linolenic acid; Amide bond; Animal model; Dopamine; Parkinson's disease; Tyrosine

Indexed keywords

2 ETHYL 1,2,3,4,6,7 HEXAHYDRO 2 HYDROXY 3 ISOBUTYL 9,10 DIMETHOXY 11BH BENZO[A]QUINOLIZINE; ANTIPARKINSON AGENT; DEXAMPHETAMINE; DOPAMINE; FATTY ACID; N (ALPHA LINOLENOYL)TYROSINE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; LINOLENIC ACID; N-(ALPHA-LINOLENOYL)TYROSINE; TYROSINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEPHAROSPASM; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; DOPAMINE RELEASE; DRUG EFFECT; DRUG MECHANISM; EYELID REFLEX; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; ANIMAL; COMPARATIVE STUDY; DRUG SCREENING; METABOLISM; METHODOLOGY; PARKINSONISM; SPRAGUE DAWLEY RAT; SYNTHESIS;

ANIMALIA;

ALPHA-LINOLENIC ACID; ANIMALS; ANTIPARKINSON AGENTS; CORPUS STRIATUM; DOPAMINE; DRUG EVALUATION, PRECLINICAL; LINOLENIC ACIDS; MALE; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; TYROSINE;

EID: 0036210948     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(01)00646-3     Document Type: Article

References (22)

1. Linoleic acid and alpha-linolenic acid lightens ultraviolet-induced hyperpigmentation of the skin
2. Fatty acid derivatives of clozapine. Prolonged antidopaminergic activity of docosahexaenoylclozapine in the rat
3. Engagement in a non-escape (displacement) behavior elicits a selective and lateralized suppression of frontal cortical dopaminergic utilization in stress
4. N-acyl-dopamines: Novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo
5. Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A
6. Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: But, why and how?
7. Alpha-linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex
8. A new perspective on cannabinoid signalling: Complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain
9. Effects of amfonelic acid, alpha-methyltyrosine, Ro 4-1284 and haloperidol pretreatment on the depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice
10. Fatty acid incorporation depicts brain activity in a rat model of Parkinson's disease
11. The role of striatal dopaminergic mechanisms in rotational behavior induced by phencyclidine and phencyclidine-like drugs
12. P450 enzymes and Parkinson's disease: The story so far
13. Cannabinoid effects in basal ganglia in a rat model of Parkinson's disease
14. Recombinant cytochrome P450 2D18 metabolism of dopamine and arachidonic acid
15. Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry
16. The fatty acid amide hydrolase (FAAH)
17. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system
18. Fatty acids and brain peptides
19. Treatment with a polyunsaturated fatty acid prevents deleterious effects of Ro4-1284
20. Essential fatty acids are mediators of brain biochemistry and cognitive functions
21. Essential fatty acids and the brain: Possible health implications